STEPHANIE CLARK: Open Payments
NPI 1427413590 · BLOOMINGTON, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 12 payments from 9 companies in 2025. Trend: 2023 $1,144 · 2024 $272 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 2 | $33 |
| Galderma Laboratories, L.P. | 2 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Biofrontera Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| UCB, Inc. | 1 | $16 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
Products named: ADBRY, DUPIXENT, NEMLUVIO, COSENTYX, SPEVIGO, Sotyktu, Bimzelx, Zoryve.
Industry payments across MN — which companies pay providers there.
